Expand NTHI Menu
NTHI MENU

NTHI Latest Press Releases

-- January 30, 2026 --

NeOnc Technologies Secures Strategic PIPE Investment led by $10 Million Investment from Cinctive Capital Management Globe Newswire 9:00 AM

-- December 15, 2025 --

NeOnc Technologies Reports Updated Clinical Results Globe Newswire 9:00 AM

-- December 1, 2025 --

NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors Globe Newswire 9:00 AM

-- November 13, 2025 --

NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High-Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026) Globe Newswire 9:00 AM

-- November 12, 2025 --

NeOnc Technologies Reports Updated Clinical Results Globe Newswire 8:00 AM

-- November 7, 2025 --

NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program Globe Newswire 9:00 AM

-- November 4, 2025 --

NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth Globe Newswire 9:00 AM

-- October 28, 2025 --

His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment Globe Newswire 9:00 AM

-- October 9, 2025 --

NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42's IROS and Expands Board of Directors Globe Newswire 9:00 AM

-- October 6, 2025 --

NeOnc Technologies and Quazar Investment Set to Close $50 Million Strategic Partnership by October 23rd Following Final UAE Tax Approvals Globe Newswire 9:00 AM

-- October 2, 2025 --

NeOnc Technologies Appoints Dr. David M. Ashley, Director of The Preston Robert Tisch Brain Tumor Center at Duke, to Scientific Advisory Board Globe Newswire 9:00 AM

-- October 1, 2025 --

NeOnc Technologies Welcomes Dr. Alexandra M. Miller, Chief of Neuro-Oncology and Co-Director of the Brain and Spine Tumor Center at NYU Langone Health's Perlmutter Cancer Center, to Its Scientific Advisory Board Globe Newswire 9:00 AM

-- September 29, 2025 --

NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board Globe Newswire 9:00 AM

-- September 22, 2025 --

NeOnc Technologies to Showcase Progress on Addressing Brain Cancer to 63 Million TV Households on "Health Uncensored with Dr. Drew" on the Lifetime Network on September 25, premiering nationwide at 8:00 a.m. ET/PT Globe Newswire 9:00 AM

-- September 10, 2025 --

Blue Gold Appoints Quazar's Sameer Salgar to Advisory Board to Establish UAE Ties and Guide Digital Gold Strategy Globe Newswire 9:40 AM
NeOnc Technologies Receives FDA Authorization to Proceed with Phase II Clinical Trial of NEO212 - A First-in-Class Oral Chemical Conjugated Chemotherapy Candidate for Brain Cancer Globe Newswire 9:00 AM
Market Data Delayed 15 Minutes